Fig. 4From: Exosomal miR-182 derived from bone marrow mesenchymal stem cells drives carfilzomib resistance of multiple myeloma cells by targeting SOX6BMSCs-Exos-containing miR-182 could be absorbed by MM cells. MM.1S and U266 cells were treated with MM-BMSCs-Exos (50μg) for 24 h. A PKH26 staining was used to assess the uptake of MM-BMSCs-Exos by MM cells. B qRT-PCR was employed to measure the expression level of miR-182 in MM cellsBack to article page